COMMUNIQUÉS West-GlobeNewswire

Biora Therapeutics to Initiate First Human Trial of BioJet™ Oral Biologic Delivery Capsule
10/09/2026
Healthy volunteer study will evaluate ingestible delivery capsule for oral, needle-free administration of adalimumab with topline data expected by early 2027 SAN DIEGO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Biora [...]
Cannara Expands Financing to an $80 Million Syndicated Credit Facility with BMO and TD Bank, Further Strengthening Its Financial Foundation for Continued Growth
10/09/2026
The new financing structure provides greater financial flexibility through an expanded $40 million revolving credit facility, reduced borrowing costs and an extended maturity to December 31, 2029 MONTREAL, Sept. 10, [...]
Cannara étend son financement à une facilité de crédit syndiquée de 80 millions de dollars auprès de BMO et de la Banque TD, renforçant ainsi davantage ses bases financières pour poursuivre sa croissance
10/09/2026
Cette nouvelle structure de financement offre une plus grande souplesse financière grâce à une facilité de crédit renouvelable portée à 40 millions de dollars, à une réduction des coûts d’emprunt et à une prolongation [...]
Erasca Announces Multiple Presentations at the Upcoming 38th EORTC-NCI-AACR Symposium
10/09/2026
Oral presentation to share updated monotherapy clinical data for ERAS-0015 including additional patients and longer follow-up, expanding on the previously reported preliminary results from the ongoing AURORAS-1 Phase 1 [...]
Electra Therapeutics Announces Initiation of a Phase 1 Trial of ELA822, a Novel SIRPγ-Specific Antibody Designed to Treat T Cell-Mediated Immune and Inflammatory Diseases
10/09/2026
Second clinical-stage asset generated from the company’s proprietary library of SIRP-targeted antibodies SOUTH SAN FRANCISCO, Calif., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Electra Therapeutics, a clinical-stage [...]
Humacyte to Present at the H.C. Wainwright 28th Annual Global Investment Conference
10/09/2026
DURHAM, N.C., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, [...]
Legend Biotech to Present Updated Long-Term and Real-World Evidence from CARVYKTI Clinical Program at the International Myeloma Society Annual Meeting
10/09/2026
Updated long-term follow-up data will be presented from CARTITUDE-2 Cohort A in patients with lenalidomide-refractory multiple myeloma after 1-3 prior lines of therapy Real-world evidence and post-authorization safety [...]
ApolloMD Welcomes Scott O’Neil to Strategic Advisory Board
10/09/2026
Healthcare executive joins board as ApolloMD brings industry leaders together to explore the future of healthcare ATLANTA, Sept. 10, 2026 (GLOBE NEWSWIRE) -- ApolloMD, a clinician-owned and clinician-led multispecialty [...]
Rhythm Pharmaceuticals Announces New Data Presentations at the European Society for Paediatric Endocrinology Meeting
10/09/2026
-- Real-world data showed reductions in BMI with up to 18 months of setmelanotide therapy in 30 paediatric patients with acquired hypothalamic obesity (HO) in France – -- Phase 3 analyses demonstrated improvements [...]
Senseonics To Participate in Upcoming Institutional Investor Conferences
10/09/2026
GERMANTOWN, Md., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose [...]
electroCore to Participate at H.C. Wainwright Global Investment Conference
10/09/2026
ROCKAWAY, N.J., Sept. 10, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the H.C. [...]
Kestra Names Daniel Finney Vice President of Research & Development
10/09/2026
KIRKLAND, Wash., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, announced today that Daniel Finney has been named [...]
Axogen Enters into Definitive Agreement to Acquire BioCircuit Technologies
10/09/2026
Acquisition adds NerveTape™, the 1st FDA-approved device for sutureless peripheral nerve repair, broadening Axogen’s addressable market within its focus markets Axogen’s commercial infrastructure, surgeon relationships [...]
Syngenta and Amoéba Seal Exclusive European Distribution Deal, Aiming to Bring a Breakthrough Biofungicide to Cereal Growers
10/09/2026
Basel, Switzerland and Chassieu, France, Sept. 10, 2026 (GLOBE NEWSWIRE) -- The exclusive agreement will span the cereals market across the European Union, the United Kingdom, Ukraine and Switzerland, with first market [...]
Syngenta et Amoéba ont conclu un accord de distribution exclusif en Europe pour proposer aux céréaliers une innovation biofongicide
10/09/2026
Bâle (Suisse) et Chassieu (France) , 10 sept. 2026 (GLOBE NEWSWIRE) -- Cet accord exclusif couvrira le marché des céréales dans l’Union européenne, au Royaume-Uni, en Ukraine et en Suisse, avec les premiers lancements [...]
EPIK Biosciences Advances Combination Medicines Across Ketamine-Based and DXM-Based Programs, Supported by 34 Provisional Drug Patent Applications
10/09/2026
Over 20 filings are ketamine-based and over 5 are dextromethorphan (DXM)-based; applications total more than 2,700 pages of scientific and technical data; Company expects to disclose the full combination portfolio later [...]
Rakovina Therapeutics Announces Appointment of Professor Petra Hamerlik to its Board of Directors
10/09/2026
Chair of Translational Neuro-Oncology at the University of Manchester, previously a member of the Company's Scientific Advisory Board, elected at the 2026 Annual General Meeting VANCOUVER, British Columbia, Sept. 10, [...]
Teitur Trophics announces successful results from Phase I clinical trial of first-in-class Parkinson’s disease peptide TT-P34
10/09/2026
Study shows TT-P34 is safe and well tolerated in healthy volunteers and patients with early-stage Parkinson’s disease (PD), with pharmacokinetics confirming robust CNS exposure Early biomarker signals are consistent [...]
Scenic Biotech Appoints Renowned Neurology Drug Development Leader Dr. Judith Walker as Chief Medical Officer
10/09/2026
Dr. Walker joins to lead Scenic's transition into clinical development and shape its clinical strategy Lead program SC6177 is advancing toward the clinic with a first-in-class approach to restoring lysosomal function, a [...]

Pages